{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:21:09Z","timestamp":1778998869305,"version":"3.51.4"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193122","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T17:51:09Z","timestamp":1523469069000},"page":"e0193122","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9438-3350","authenticated-orcid":true,"given":"Nicolas","family":"Belhomme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Jouneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Bouzill\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Decaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Lederlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette","family":"Perlat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"J\u00e9go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"D Valeyre","year":"2014","journal-title":"Lancet"},{"key":"ref2","first-page":"736","article-title":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/thx.51.3.238","article-title":"British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment","volume":"51","author":"GJ Gibson","year":"1996","journal-title":"Thorax"},{"key":"ref4","first-page":"52","article-title":"The late follow-up of chronic sarcoid patients previously treated with corticosteroids","volume":"15","author":"G Rizzato","year":"1998","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"MC Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s10875-012-9754-4","article-title":"Human chitotriosidase: a sensitive biomarker of sarcoidosis","volume":"33","author":"E Bargagli","year":"2013","journal-title":"J Clin Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1378\/chest.09-1975","article-title":"Comparative evaluation of serum markers in pulmonary sarcoidosis","volume":"137","author":"S Miyoshi","year":"2010","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.rmed.2014.02.002","article-title":"Serial chitotriosidase measurements in sarcoidosis\u2014two to five year follow-up study","volume":"108","author":"M Harlander","year":"2014","journal-title":"Respir Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0895-4356(93)90150-Y","article-title":"The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis","volume":"46","author":"K Takada","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/thx.49.7.688","article-title":"Specification and quantitation of circulating immune complexes in the serum of patients with active pulmonary sarcoidosis","volume":"49","author":"N Schoenfeld","year":"1994","journal-title":"Thorax"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0272-5231(05)70415-9","article-title":"Immunology of sarcoidosis","volume":"18","author":"YP Kataria","year":"1997","journal-title":"Clin Chest Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.0954-6820.1981.tb09819.x","article-title":"Relationship between circulating immune complexes and angiotensin-converting enzyme in pulmonary sarcoidosis","volume":"210","author":"FK R\u00f8mer","year":"1981","journal-title":"Acta Med Scand"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1465-9921-6-78","article-title":"Serum biomarkers in interstitial lung diseases","volume":"6","author":"A Tzouvelekis","year":"2005","journal-title":"Respir Res"},{"key":"ref14","first-page":"913","article-title":"An Integrated Workflow For Secondary Use of Patient Data for Clinical Research","volume":"216","author":"G Bouzill\u00e9","year":"2015","journal-title":"Stud Health Technol Inform"},{"key":"ref15","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"RP Baughman","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref16","first-page":"204","article-title":"Two year prognosis of sarcoidosis: the ACCESS experience","volume":"20","author":"MA Judson","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref17","first-page":"623","article-title":"Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy","volume":"111","author":"JE Gottlieb","year":"1997","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2007-970335","article-title":"Extrapulmonary sarcoidosis","volume":"28","author":"MA Judson","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"ref19","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool","volume":"31","author":"MA Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1183\/09031936.00138913","article-title":"Relapses of sarcoidosis: what are they and can we predict who will get them?","volume":"43","author":"RP Baughman","year":"2014","journal-title":"Eur Respir J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/jcp.33.6.528","article-title":"Biochemical findings in sarcoidosis","volume":"33","author":"PR Studdy","year":"1980","journal-title":"J Clin Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","article-title":"Course and prognosis of sarcoidosis around the world","volume":"57","author":"LE Siltzbach","year":"1974","journal-title":"Am J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e0143371","DOI":"10.1371\/journal.pone.0143371","article-title":"Cumulative Incidence and Predictors of Progression in Corticosteroid-Na\u00efve Patients with Sarcoidosis","volume":"10","author":"Y Inoue","year":"2015","journal-title":"PloS One"},{"key":"ref24","first-page":"253","article-title":"Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy","volume":"55","author":"GM Ainslie","year":"1985","journal-title":"Q J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF02714452","article-title":"Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis","volume":"165","author":"RP Baughman","year":"1987","journal-title":"Lung"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1164\/rccm.200705-742OC","article-title":"Phenotyping sarcoidosis from a pulmonary perspective","volume":"177","author":"A Prasse","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis","volume":"183","author":"RP Baughman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1183\/09031936.00050106","article-title":"Genotype-corrected reference values for serum angiotensin-converting enzyme","volume":"28","author":"H Biller","year":"2006","journal-title":"Eur Respir J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1749-6632.1986.tb18537.x","article-title":"Factors affecting outcome of sarcoidosis. Influence of race, extrathoracic involvement, and initial radiologic lung lesions","volume":"465","author":"HL Israel","year":"1986","journal-title":"Ann N Y Acad Sci"},{"key":"ref30","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"MA Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"RP Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.04.00070503","article-title":"Sarcoidosis: social predictors of severity at presentation","volume":"24","author":"DL Rabin","year":"2004","journal-title":"Eur Respir J"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"M Mirsaeidi","year":"2015","journal-title":"Chest"},{"key":"ref34","first-page":"128","article-title":"Mortality among African American women with sarcoidosis: data from the Black Women\u2019s Health Study","volume":"30","author":"MH Tukey","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/qjmed\/hcl038","article-title":"Presenting characteristics as predictors of duration of treatment in sarcoidosis","volume":"99","author":"RP Baughman","year":"2006","journal-title":"QJM"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-0030-1262207","article-title":"Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET","volume":"31","author":"U Costabel","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1378\/chest.104.2.352","article-title":"Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis","volume":"104","author":"RH Winterbauer","year":"1993","journal-title":"Chest"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1749-6632.1986.tb18548.x","article-title":"The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis","volume":"465","author":"H Eule","year":"1986","journal-title":"Ann N Y Acad Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T22:44:35Z","timestamp":1720219475000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193122"}},"subtitle":[],"editor":[{"given":"Elliott D.","family":"Crouser","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193122","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,11]]}}}